Skip to main content
Autobound logo
AbbVie8-K: Restructuring charge

AbbVie completes acquisition of Apogee Therapeutics, signaling post-merger integration initiative.

Read at SEC EDGAR

What happened

The completion of the Apogee Therapeutics acquisition on September 3, 2026, triggers a significant post-merger integration effort.

Source

SEC EDGARSep 3, 2026

Current report (Form 8-K)

AbbVie 8-K

Filing excerpt

On September 3, 2026, AbbVie Inc. (the “Company”) issued a press release announcing the completion of its acquisition of Apogee Therapeutics, Inc.

sec.gov/Archives/edgar/data/1551152/000110465926104940/tm2624674d1_8k...Read the full source

Other signals in this filing (2)

Extracted by Autobound

From the Signal API record
Signal
8-K: Restructuring charge

What this signalsFilings often name leadership changes, deals and spending plans.

Form
8-K
Filed
Sep 3, 2026

More from AbbVie

Company page →

More 8-K signals at other companies

The full record

From the Signal API record

Details

CIK
1551152
Accession number
0001104659-26-104940
Timeframe
Immediate
Filing year
2026
Why it matters
Vendor review likely
Signal category
Financial

Extraction

Confidence
High
Relevance
85%
Sentiment
Neutral
Detected
Sep 8, 2026
signal_type
sec-8k
signal_subtype
restructuringCharge

Use this data

Get every 8-K signal for AbbVie and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at AbbVie this week?”

    MCP setup guide

  2. Send it to your own tools

    The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

    Signal API

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Start Free1,000 free creditsUse it in Claude via MCP
Show the full JSONThe record on this page and the API request

GET /v1/signals/db59b7e7-862a-4518-8856-72d07c7c9532 returns this record as JSON. POST /v1/companies/enrich returns every signal for abbvie.com.

{
  "signal_id": "db59b7e7-862a-4518-8856-72d07c7c9532",
  "signal_type": "sec-8k",
  "signal_subtype": "restructuringCharge",
  "detected_at": "2026-09-08T07:05:00.7+00:00",
  "company": {
    "name": "AbbVie",
    "domain": "abbvie.com"
  },
  "data": {
    "detail": "The completion of the Apogee Therapeutics acquisition on September 3, 2026, triggers a significant post-merger integration effort. This creates immediate opportunities for vendors specializing in system consolidation, process harmonization, and organizational restructuring to address complex integration challenges.",
    "metrics": {
      "timeframe": "immediate"
    },
    "summary": "AbbVie completes acquisition of Apogee Therapeutics, signaling post-merger integration initiative.",
    "excerpts": "On September 3, 2026, AbbVie Inc. (the “Company”) issued a press release announcing the completion of its acquisition of Apogee Therapeutics, Inc.",
    "relevance": 0.85,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1551152/000110465926104940/tm2624674d1_8k.htm",
    "filing_date": "2026-09-03",
    "filing_year": 2026,
    "sales_relevance": "Vendor review likely",
    "signal_category": "financial"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.